Skip to main content

Table 3 Factors associated with the occurrence of cardiovascular events

From: Cardiovascular disease events within 5 years after a diagnosis of breast cancer

N = 682ModalityNo EventEvent
HER2 overexpression (N = 682)Y551 (85%)25 (73.5%)
N69 (10.6%)9 (26.5%)
NA28 (4.3%)0 (0%)
Left breast (N = 682)Y340 (52.5%)17 (50%)
N308 (47.5%)17 (50%)
NA0 (0%)0 (0%)
Triple negative status (N = 682)N590 (91%)32 (94.1%)
Y56 (8.6%)2 (5.9%)
NA2 (0.3%)0 (0%)
Metastatic at diagnosis (N = 682)Inf IV634 (97.8%)33 (97.1%)
IV14 (2.2%)1 (2.9%)
NA0 (0%)0 (0%)
UICC (N = 682)<III573 (88.4%)19 (55.9%)
> = III75 (11.6%)15 (44.1%)
NA0 (0%)0 (0%)
Chemotherapy with anthracyclines (N = 682)Y162 (25%)12 (35.3%)
N73 (11.3%)9 (26.5%)
NA413 (63.7%)13 (38.2%)
Hormonotherapy (N = 682)Y525 (81%)26 (76.5%)
N123 (19%)8 (23.5%)
NA0 (0%)0 (0%)
Pre-existing cardiovascular disease risk factors (N = 682)N332 (51.2%)9 (26.5%)
Y315 (48.6%)25 (73.5%)
NA1 (0.2%)0 (0%)